# ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease

> **NCT04899518** · PHASE2,PHASE3 · COMPLETED · sponsor: **Allysta Pharmaceutical** · enrollment: 922 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** ALY688 Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04899518
- **Lead sponsor:** Allysta Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-19
- **Primary completion:** 2023-03-14
- **Final completion:** 2023-03-14
- **Target enrollment:** 922 (ACTUAL)
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04899518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04899518, "ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04899518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*